Navigation Links
Executive Order on Embryonic Stem Cells 'A Sad Victory of Politics Over Science and Ethics,' Says Cardinal Rigali
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, chairman of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities, today called President Obama's executive order on embryonic stem cell research "a sad victory of politics over science and ethics." Under the order, for the first time in U.S. history, federal tax dollars will be used to encourage researchers to destroy live human embryos for stem cell research. Cardinal Rigali also cited a January 16 letter in which Cardinal Francis George, president of the USCCB, urged President-elect Obama not to issue such an order. Cardinal Rigali's statement follows:

"President Obama's new executive order on embryonic stem cell research is a sad victory of politics over science and ethics. This action is morally wrong because it encourages the destruction of innocent human life, treating vulnerable human beings as mere products to be harvested. It also disregards the values of millions of American taxpayers who oppose research that requires taking human life. Finally, it ignores the fact that ethically sound means for advancing stem cell science and medical treatments are readily available and in need of increased support.

"In his January 16th letter to President-elect Obama, Cardinal George, writing as President of the USCCB, cited three reasons why such destructive research is 'especially pointless at this time':

  • 'First, basic research in the capabilities of embryonic stem cells can be and is being pursued using the currently eligible cell lines as well as the hundreds of lines produced with nonfederal funds since 2001.
  • 'Second, recent startling advances in reprogramming adult cells into embryonic-like stem cells - hailed by the journal Science as the scientific breakthrough of the year - are said by many scientists to be making embryonic stem cells irrelevant to medical progress.
  • 'Third, adult and cord blood stem cells are now known to have great versatility, and are increasingly being used to reverse serious illnesses and even help rebuild damaged organs. To divert scarce funds away from these promising avenues for research and treatment toward the avenue that is most morally controversial as well as most medically speculative would be a sad victory of politics over science.'

"If the government wants to invest in hope for cures and promote ethically sound science, it should use our tax monies for research that everyone, at every stage of human development, can live with."


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University of Maryland Business School Continues Executive Education Leadership With Maryland State Medical Society Partnership
2. Pelosi Statement on President Obamas Executive Order on Stem Cell Research
3. Reveille Software Reaches Customer Milestone and Expands Executive Team
4. Embryonic Stem Cell Research Executive Order Places Politics Ahead of Science, Says Michigan Catholic Conference
5. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
6. It Must Be Friday Night: Pres. Obama to Issue Deadly Executive Order
7. HMS Holdings Corp. Announces Executive Promotions
8. RoundTable Appoints Senior Healthcare Executives
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp.
10. Authentidate Holding Corp. Non-executive Chairman F. Ross Johnson Steps Down From Board of Directors
11. Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the Presidents 2010 Budget Proposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
Breaking Medicine Technology: